baber/WOPTO huggingface dataset:
Patent CA-2587806-A1 (CA)
Title: Chair for video game
Inventor: PERIGNY SYLVAIN
IPC: A63F13/98
Filed: 2007-05-07
Abstract: A chair suitable for use with a video game, the chair having a seat portion and a back portion, the back portion having a pair of deformation devices, said deformation devices being designed to cause increased pressure on a portion of an occupant's bac k. Preferably, the deformation devices are linked to the accelerator and steering wheel to simulate turning and acceleration.
Patent CA-2590537-A1 (CA)
Inventor: CARLSON STEVEN R
IPC: A61K38/48
Filed: 1994-12-16
Abstract: The present invention provides a method for relieving pain, associated with muscle contractions, a composition and a method of treating conditions such as cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretions and a method for treating smooth muscle disorders including, but not limited to, spasms in the sphincter of the cardiovascular arteriole, gastrointestinal system, urinary, gall bladder and rectum, which method comprises administering to the patient suffering from said disorder or condition a thera-peutically effective amount of Botulinum toxin selected from a group consisting of Botulinum toxin types B, C, D, E, F and G.
Patent CA-2592902-A1 (CA)
Title: Use of the fp header to signal the rnc that the node b has not been able to determine or has not been able to accurately determine the number of retransmissions
Inventor: NAKAMATA MASATOSHI
IPC: H04L1/1812
Filed: 2005-12-30
Abstract: The FP header is used to signal the RNC that the Node B has not been able to determine or has not been able to accurately determine the number of retransmissions. A first embodiment is to reserve a bit pattern for use in the ‘Number of HARQ retransmissions’ field on the Iub frame protocol DATA FRAME header to indicate that Node B does not know the actual number of retransmissions. A second embodiment is to define a one bit flag on Iub/Iur FP DATA FRAME header to indicate that the value set in the “Number of HARQ Retransmissions” in the FP header is an estimated/guessed value by Node B or not.
Patent CA-2594273-A1 (CA)
Inventor: KALTSATOS VASSILIOS
IPC: A61K9/14
Filed: 2005-12-20
Abstract: L'invention est un procédé de préparation d'une composition pharmaceutique solide à libération prolongée et contrôlée par traitement aux hautes pressio ns d'une composition solide comprenant au moins un principe actif et au moins u n polymère. L'invention concerne également les compositions pharmaceutiques solides ainsi obtenues.
Patent CA-2595438-A1 (CA)
Inventor: HOPKINS SAMUEL P
IPC: H04L29/06
Filed: 2005-01-21
Abstract: L'invention concerne un noeud d'amélioration destiné à être déployé dans un réseau poste à poste. Le noeud d'amélioration selon l'invention est programmé pour surveiller le réseau afin de recevoir des messages de communication et transmettre lesdits messages de communication, en modifiant facultativement les paramètres du rayon de communication en une valeur optimale ou presque optimale. Le noeud d'amélioration peut transmettre des messages en provenance d'un réseau vers un autre réseau ou en provenance d'un réseau vers le même réseau. L'invention porte également sur un procédé qui permet de surveiller les messages de communication à la recherche d'objets choisis par les noeuds dans un réseau poste à poste. Le procédé de l'invention consiste à interposer le noeud d'amélioration dans le réseau. Le noeud d'amélioration comporte au moins un objet stocké qui correspond à un objet message de communication stocké dans ledit noeud d'amélioration, et surveille le réseau afin de détecter des messages de communication correspondant à au moins l'un des objets stockés, et décide de les transmettre ou non ou de modifier les paramètres de rayon des messages de communication sur la base d'une quelconque programmation ou configuration définie.
Patent CA-2597868-A1 (CA)
Inventor: NIEBAUER MICHAEL FREDERICK
IPC: A61Q5/00
Filed: 2006-02-23
Abstract: A multi-liquid phase composition wherein said phases are visually distinctive.  These compositions combine multiple phases for creating personal care compositions.
Patent CA-2598467-A1 (CA)
Inventor: WINTERFLOOD JOHN
IPC: G01V7/16
Filed: 2006-08-31
Abstract: A gravity gradiometer is disclosed which has a sensor in the form of bars (41 and 42) which are supported on a mounting (5) which has a first mount section (10) and a second mount section (20). A first flexure web (33) pivotally couples the first and second mount sections about first axis. The second mount has first part (25), a second part (26) and a third part (27). The parts (25 and 26) are connected by second flexure web (37) and the parts (26 and 27) are connected by third flexure web (35). The bars (41 and 42) are located in housings (45 and 47) and form a monolithic structure with the housings (45 and 47) respectively. The housings (45 and 47) are connected to opposite sides of the second mount section 20. The bars (41 and 42) are connected to their respective housings by flexure webs (59).
Patent CA-2599425-A1 (CA)
Title: Substituted gamma lactams as therapeutic agents
Inventor: OLD DAVID W
IPC: A61K31/402
Filed: 2006-03-06
Abstract: Use of a compound of Formula (I) or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein, where Y, A, and B are as described herein, for use as medicaments in the treatment of the inflammatory bowel disease or glaucoma. Some compounds of Formula (I) are new.
Patent CA-2603319-A1 (CA)
Inventor: DIAZ STEPHEN HUNTER
IPC: B05D3/00
Filed: 2006-03-28
Abstract: The beneficial agent is applied into the holes in a medical device in a dry particulate form and is adhered in the hole in a manner that allows release of the drug in a controlled manner. The drug material would be formed into particles and placed in the holes. The solvent would be added to partially liquefy and adhere the drug into the holes. After application of the solvent, the particles are adhered together in a substantially uniform drug containing matrix. The particles may include drhug alone or drug in combination with other materials including a matrix.
Patent CA-2604595-A1 (CA)
Title: Lignan-containing compositions
Inventor: SUN SAM Z
IPC: A23L9/10
Filed: 2006-04-03
Abstract: Compositions are provided that includes a lignan, and an additional compound such as an isoflavone , a tocopherol , a phytosterol , a polyphenol , a catechin, an anthocyanin, an astaxanthin, or a glucosamine . The compositions can be formulated as a dietary supplement, in tablet , powder or liquid form, or can be incorporated into a food product . They are useful in the treatment of various diseases.
Patent CA-2604647-A1 (CA)
Inventor: KAARET THOMAS W
IPC: D06L4/75
Filed: 2005-09-09
Abstract: Disclosed herein is a viscoelastic oxidizing formulation comprising, in aqueous solution: an effective amount of an oxidizing compound; a thickening system which comprises (i) at least one alkali metal soap and (ii) a hydrotrope selected from the group consisting of amine oxides, betaines and mixtures thereof, each in amounts appropriate to create a viscoelastic composition having a Zero-shear viscosity in the range of 140-265 cP; a Stress ~ value greater than 10 Pa and a Relaxation constant greater than 0.05 second;  and a buffer/electrolyte in an amount effective to stabilize the oxidizing compound. The oxidizing formulations may further be formulated to have an oxidant stable opacifier or colorant.
Patent CA-2612441-A1 (CA)
Title: Oral composition comprising dimethicone copolyol
Inventor: URQUHART DAVID
IPC: C08G77/46
Filed: 2006-06-28
Abstract: Oral compositions comprising silicone polyols are described for lubricating and hydrating the buccal cavity and are of benefit in alleviating the symptoms of xerostomia (dry mouth).
Patent CA-2612811-A1 (CA)
Title: Amylases for pharmaceutical use
Inventor: SVENDSEN ALLAN
IPC: A61K38/47
Filed: 2006-06-16
Abstract: The pharmaceutical use of amylases related to Bacillus alpha-amylases of SEQ  ID NOs: 1-3, optionally in combination with a lipase and/or a protease.  Examples of medical indications are: Treatment of digestive disorders, pancreatic exocrine insufficiency (PEI), pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II. The amylases of SEQ ID NOs: 1-3 are variants of amylases from Bacillus stearothermophilus, Bacillus licheniformis and Bacillus sp. The amylases of the invention have an improved efficacy in vivo, an improved pH-profile, a high specific activity, and/or an improved starch degradation profile.
Patent CA-2614041-A1 (CA)
Inventor: WILLIAMS BRYCE ALAN
IPC: C07C5/48
Filed: 2006-06-28
Abstract: The present invention provides a process for the production of olefins, which process comprises: (a) providing an autothermal cracking unit having at least two reactors, (b) autothermally cracking a first hydrocarbon stream by contacting said stream with a first catalyst bed in the presence of molecular oxygen containing gas in one or more first reactors to produce one or more first product streams, (c) autothermally cracking a second hydrocarbon stream by contacting said stream with a second catalyst bed in the presence of molecular oxygen containing gas in one or more second reactors to produce one or more second product streams, (d) separating at least one olefm-containing product stream from the first and second product streams, characterised in that at least two of the following apply: (i) the first and second catalyst beds are different, (ii) the first and second hydrocarbon streams are different, and (iii) the second hydrocarbon stream is not cracked to optimise production of C2 to C4 olefins.
Patent CA-2614082-A1 (CA)
Title: Compositions and methods for protein deaggregation
Inventor: DUA RAJESH
IPC: C07K16/18
Filed: 2006-07-24
Abstract: Compositions and methods are provided for achieving the deaggregation of binding proteins including, but not limited to, protein ligands, soluble receptors, antibodies, antibody fragments, variable fragment single-chain antibodies (scFv), and small modular immunopharmaceutical products (SMIP~  products). The compositions, which are suitable for the deaggregation of highly concentrated solutions of binding proteins, contain one or more chaotrope, are typically formulated at an acidic pH, and may be used to provide binding proteins suitable for the preparation of pharmaceutical compositions and administration in vivo to a patient.
Patent CA-2614409-A1 (CA)
Title: Procede servant a broyer et a preparer des poudres et compositions produites par celui-ci
Inventor: TALTON JAMES D
IPC: B02C19/06
Filed: 2006-06-30
Abstract: Procédé de broyage d'une poudre comprenant l'introduction d'un flux gazeux contenant un liquide cryogénique et un gaz vecteur de médicament dans un broyeur à jet et le broyage d'une poudre avec le broyeur à jet en une ou plusieurs passes de broyage ; produit qui est produit par le procédé ; appareil de broyage comprenant un système d'introduction de gaz cryogénique, un chargeur de poudre, un broyeur à jet principal et au moins un orifice de sortie servant à recueillir la poudre.
Patent CA-2614584-A1 (CA)
Inventor: PEREZ LOUIS
IPC: A45D20/12
Filed: 2001-09-14
Abstract: The invention relates to a portable, cordless, hair dryer/blower that has an elongated hollow body portion with a mass center line and including therein a blower motor and a heating element and having a posterior end and an anterior end. A handle portion has a longitudinal axis extending substantially transversely from and along the mass center line of the elongated body portion. The handle portion includes switch controls for operating the heating element and the blower motor. A power source has a flat base and a mass center line that, when the power source is attached to the handle portion lies substantially along the longitudinal axis of the handle and the mass center line of the elongated body portion to provide power to the manual controls and to provide a flat base structure for enabling the hair dryer/blower to stand alone.
Patent CA-2617024-A1 (CA)
Title: Applications of cross-linked silicone gel in personal care products
Inventor: SLAVASHEVICH PAUL
IPC: A61K8/89
Filed: 2006-08-22
Abstract: The present invention relates to the use of cross-linked silicone gel, in particular, a polymerization product of a polyorganohydrosiloxane, with the proposed INCI name (Dimethicone/polymethylalltyl siloxane copolymer), in cosmetic applications to provide unexpected characteristics related to formulations incorporating these silicone gels.
Patent CA-2617193-A1 (CA)
Inventor: CHRISTENSEN GUSTAV
IPC: G06F17/10
Filed: 2008-01-10
Abstract: Methods are provided for fitting a curve to a set of data values using a least absolute value (LAV) cost function. The set of data values may comprise m sets of data values.  The method takes advantage of contraction mapping to determine a number n < m of individual equations which are interpolated by the curve to be fitted, where n corresponds to the number of parameters x1, x2,..., x n to be ascertained for the curve to be fitted. The method then involves solving the n selected equations to determine the n parameters x1, x2,..., x n of the curve to be fitted. Selection of these parameters ensures that the curve to be fitted minimizes the LAV cost function.
Patent CA-2618279-A1 (CA)
Title: Emergency case
Inventor: STERN MARK D
IPC: G06Q30/02
Filed: 2008-01-22
Abstract: An emergency case is described that includes compartments for documents and photo albums, as well as closeable compartments for retaining a variety of small, personal objects.
Patent CA-2618978-A1 (CA)
Inventor: KEMENCZY ZOLTAN
IPC: H03M13/41
Filed: 2006-08-23
Abstract: A wireless communications device may include a housing and a wireless transmitter and a wireless receiver carried by the housing. The wireless receiver may include a joint demodulation filter for reducing co-channel interference between a desired signal and a co-channel interfering signal which may include an input receiving samples of the desired signal and the co-channel interfering signal, a Viterbi decoder, and a first signal path between the input and the Viterbi decoder comprising a first filter. The joint demodulation filter may further include a second signal path between the input and the Viterbi decoder and comprising a linear finite impulse response (FIR) modeler for generating a channel impulse response estimate for the co-channel interfering signal. Additionally, a third signal path may be between the input and the Viterbi decoder and include a whitened matched filter for generating a channel impulse response estimate for the desired signal.
Patent CA-2621238-A1 (CA)
Inventor: AIDUN MEHRDAD
IPC: G06F11/00
Filed: 2006-09-29
Abstract: Systems and methods operating over extended distances provide for recovery of data and operational continuity of computer applications accessing data within an information technology system if an event occurs effecting access to the data. In one embodiment, an extended distance data recovery system (100) includes first, second and third data storage devices (112, 122, 132) located at respective first, second and third sites (110, 120, 130). The second and third sites (120, 130) are remotely located from the first site (110) with the second site (120) being nearby the first site (110). The first data storage device (112) has data (116) stored thereon. A computer executable control process (150) directs synchronous replication of the data (116), either at the storage level or at the application level, onto the second data storage device (122). The control process (150) also directs asynchronous replication of the data (116) from the second data storage device (122) onto the third data storage device (132) and coordinates among the three sites (110, 120, 130) the state of application servers, storage replication, network address changes, and other prerequisite aspects of the IT infrastructure required to allow the application servers to successfully start at the disaster recovery site.
Patent CA-2622765-A1 (CA)
Inventor: LAYZER JULIANA M
IPC: C12Q1/68
Filed: 2006-09-15
Abstract: Focused aptamer libraries are constructed in accordance with a proteome (i.e., complex mixture of native biomolecules). The libraries may be screened to identify one or more candidate aptamers with desired biological activities other than specific binding to a target. Aptamers which are selected or derivatives thereof may be used for those specific activities in biological systems. Any combination of deconvoluting a focused library (functional profiling), increasing frequencies of particular aptamers in a focused library (Laser SELEX), and decreasing frequencies of particular aptamers in a focused library (DeSELEX) may be performed prior to assaying biological activity.
Patent CA-2626214-A1 (CA)
Title: Nouvelle utilisation de composes il-1beta
Inventor: MUNDEL TREVOR
IPC: A61P37/00
Filed: 2006-10-24
Abstract: La présente a trait à une nouvelle utilisation de composés de disruption du récepteur IL-1ß-ligand/IL-1 (désignés composés "IL-1bêta), tels que des composés à base de petites molécules de disruption d'interaction du récepteur IL-1ß-ligand/IL-1 d'anticorps du récepteur IL-1ß ou IL-1, par exemple, des composés de liaison à IL-1ß ou des composés de liaison au récepteur IL-1, et/ou des composés à base d'ARN réduisant des niveaux de protéines soit de ligands IL-1ß ou du récepteur IL-1, dans le traitement et/ou la prévention de syndromes auto-inflammatoires, par exemple, le syndrome de l'arthrite rhumatoïde juvénile ou de l'arthrite rhumatoïde de l'adulte et à des procédés de traitement et/ou de prévention de syndromes auto-inflammatoires, par exemple, le syndrome de l'arthrite rhumatoïde juvénile ou de l'arthrite rhumatoïde de l'adulte, chez des mammifères, notamment des humains.
Patent CA-2627937-A1 (CA)
Inventor: HSIEH CHIH-CHIANG
IPC: H04B7/15
Filed: 2008-04-01
Abstract: A method, a wireless communication system, a tangible machine-readable medium, and a communication apparatus for transmitting downlink hybrid automatic repeat request (HARQ) packets based on a multi-hop relay standard are provided. The wireless communication system comprises a BS, an SS, and a plurality of RSs. The BS  transmits a plurality of first downlink HARQ packets to the RSs. After receiving one of the first downlink HARQ packets, at least one of the RSs replies a first ACK to the BS  and retrieves a second downlink HARQ packet in the first downlink HARQ packet. Then, the at least one of the RSs transmits the second downlink HARQ packet to the SS. And the second downlink HARQ packet is the same as a part of one of the first downlink HARQ  packets.
Patent CA-2628335-A1 (CA)
Title: A panel assembly
Inventor: CAROLAN JAMES
IPC: E04D3/36
Filed: 2006-11-15
Abstract: A building panel assembly comprises a translucent panel (2) and a spacer (4) to bridge the gap between the translucent panel (2) and a support such as a purlin (3). The spacer (4) is not pre-attached to the translucent panel (2) but is coupled on site to the purlin (3) using a magnetic effect. In this way the spacer is conveniently held in place on the purlin whilst the translucent panel is aligned and then fixed in place using a fixing pin (5).
Patent CA-2632673-A1 (CA)
Inventor: BLACK MARK
IPC: A61K31/519
Filed: 2006-12-07
Abstract: The present invention discloses and claims a method of treating cognition deficits in a patient suffering from schizophrenia by administering to said patient a therapeutically effective amount of a CBl receptor antagonist as described herein. In another aspect, this invention also discloses and claims a combination of one or more CBl receptor antagonists and of one or more antipsychotic agents useful in the treatment of psychiatric disorders . The combination of this invention provides beneficial results in that the combination improves positive and negative symptoms of schizophrenia, while reducing weight gain and catalepsy induced by antipsychotic drugs .
Patent CA-2632984-A1 (CA)
Title: Dialysis solution preparation water, dialysis solution using such water, method of producing dialysis solution, and dialysis equipment
Inventor: KABAYAMA SHIGERU
IPC: C02F1/46
Filed: 2006-06-19
Abstract: A water for preparing a dialysate which is a water having a dissolved hydrogen concentration of from 50 to 600 ppb and a pH value of from 7 to 10 and satisfying the water quality standards as specified in ISO 13959 and to be used in preparing a dialysate by diluting a stock agent for a dialysate containing at least 50 ng/mL of glucose decomposition products; a method of preparing a dialysate by diluting a stock agent for a dialysate by using the above water; and the dialysate thus obtained. It is possible to provide a dialysate by which undesirable effects of glucose decomposition products on the living body can be inhibited, a water for preparing a dialysate to be used therefore, a method of producing a dialysate and a dialyzer can be provided by using a dialyzer having a means of supplying a water for preparing a dialysate, which is a water having a dissolved hydrogen concentration of from 50 to 600 ppb and a pH value of from 7 to 10 and satisfying the water quality standards as specified in ISO 13959, a means of storing a stock agent for a dialysate containing at least 50 ng/mL of glucose decomposition products, and a means of preparing a dialysate by diluting the stock agent for a dialysate with the water for preparing a dialysate.
Patent CA-2634601-A1 (CA)
Title: Malononitrile compounds
Inventor: RACK MICHAEL
IPC: C07D277/32
Filed: 2006-12-13
Abstract: Compounds of formula I wherein X is O or S(=O)n; n is 0,1 or 2; R1 is optionally substituted alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, haloalkynyl, cycloalkyl, halocycloalkyl, cycloalkenyl, halocycloalkenyl, phenyl, hetaryl, phenylalkyl, hetaryl alkyl, optionally fused to phenyl, hetaryl or heterocyclyl; A is -NR b2, -C(=G)GR b, -C(=G)NR b2, -C(=NOR b)R b, C(=G)[N=SR b2], -C(=G)NR b-NR b2, C2-C6-alkandiyl, C2-C6-alkenediyl, C1-C3-alkyl-G-C1-C3-alkyl, wherein R b is as defined in the description, or optionally substituted phenyl, hetaryl, heterocyclyl, optionally fused to phenyl or heterocyclyl; B is an optionally substituted saturated or partially unsaturated hydrocarbon chain with 1 to 3 carbon chain atoms; D  is an optionally substituted saturated or partially unsaturated hydrocarbon chain with 1 to 5 carbon chain atoms or C3-C6-cycloalkyl;  G is oxygen or sulfur; or the enantiomers or diastereomers or salts or N-oxides thereof, processes for preparing the compounds I, pesticidal compositions and synergistic mixtures comprising compounds I, methods for the control of insects, acarids or nematodes by contacting the pests or their food supply, habitat or breeding grounds with a pesticidally effective amount of compounds formula I, and a method for treating, controlling, preventing or protecting animals against infestation or infection by parasites which comprises orally, topically or parenterally administering or applying to the animals a parasiticidally effective amount of compounds of formula I.
Patent CA-2634608-A1 (CA)
Title: Inhibition of the anti-fviii immune response
Inventor: KAVERI SRINI V
IPC: C07K14/755
Filed: 2006-12-22
Abstract: L'invention concerne un composé capable d'inhiber l'endocytose du FVIII (Facteur VIII) par les cellules du système immunitaire capables d'endocyter l'antigène et l'utilisation thérapeutique d'un tel composé pour la fabrication d'un, médicament destiné au traitement des hémophiles pour diminuer l'immunogénicité du FVIII et/ou augmenter la demi-vie du FVIII.